Friday, June 2, 2017

A startup that charges $8,000 for young blood transfusions swears they’re worth every penny

And so it starts. This company is touting disease-fighting, but as I understand it the benefit that has been proven (at least in mice) is reduced senescence:

https://qz.com/996190/ambrosia-says-a-transfusion-of-young-blood-plasma-lowered-disease-markers-in-a-human-trial/

No comments:

AI Lab Partners Are Rewiring the Hunt for New Drugs

https://singularityhub.com/2026/05/21/ai-lab-partners-are-rewiring-the-hunt-for-new-drugs/